Edition:
United Kingdom

Dynavax Technologies Corp (DVAX.OQ)

DVAX.OQ on NASDAQ Stock Exchange Capital Market

3.63USD
7:48pm BST
Change (% chg)

$-0.17 (-4.47%)
Prev Close
$3.80
Open
$3.81
Day's High
$3.82
Day's Low
$3.63
Volume
133,883
Avg. Vol
354,470
52-wk High
$16.30
52-wk Low
$3.58

About

Dynavax Technologies Corporation is a clinical-stage immunotherapy company. The Company is focused on leveraging the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $1,380.17
Shares Outstanding(Mil.): 59.75
Dividend: --
Yield (%): --

Financials

  DVAX.OQ Industry Sector
P/E (TTM): -- 69.29 32.55
EPS (TTM): -2.48 -- --
ROI: -72.82 8.90 13.82
ROE: -73.07 10.04 15.24

Earnings vs. Estimates